#Thread: As @Novartis’ vildagliptin (#Galvus) goes off-patent in #India today and a scramble is expected, some tidbits about this hugely successful drug.
-Vildagliptin, from a class of drugs called DPP-4, was launched in India in 2008 with a licensing arrangement with USV (1)— Vikas Dandekar (@VikasReports) December 10, 2019
Excellent thread.
And a story of my own. When I was 18, I went off to Aurangabad to play the Maharashtra u-19 chess championship. This was in the early '90s. One detail: I had a beard then. (The Punjabi side of my genes, I guess.) + https://t.co/uL3G0LSdbb
— Amit Varma (@amitvarma) December 10, 2019
Are my mutual funds safe, they are also with Karvy as Registrar!
1. No no, that's not correct
2. Karvy is just a record keeper of mutual funds
3. They can't do this to mutual funds.MFs are nothing to worry! (atleast I think so)
**** End ***
— Nagpal Manoj (@NagpalManoj) December 5, 2019
At last finished reading The Narrow Corridor by Acemoglu and Robinson. This is a companion to their earlier book, Why Nations Fail. @pseudoerasmus has tweeted extensively about the book. @_alice_evans has done a podcast with Acemoglu. Long thread follows.
— Sri Thiruvadanthai (@teasri) December 7, 2019
It’s time for a quick #EconCookingTwitter thread on one of my all-time favorites, duck confit. You might have had it in Paris, in a French bistro, or out of a can, but it’s surprisingly easy to prepare at home. It takes time, but it can be pre-prepared, ready to reheat. 🇫🇷🦆 1/17 pic.twitter.com/QzBIaQbBel
— Steven Hamilton (@SHamiltonian) December 8, 2019